Cibus, Inc. (CBUS)
NASDAQ: CBUS · IEX Real-Time Price · USD
9.40
-0.19 (-1.98%)
At close: Jul 19, 2024, 4:00 PM
9.42
+0.02 (0.21%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Cibus Market Cap
Cibus has a market cap or net worth of $244.92 million as of July 22, 2024. Its market cap has increased by 1,490.41% in one year.
Market Cap
244.92M
Enterprise Value
416.87M
1-Year Change
1,490.41%
Ranking
Category
Stock Price
$9.40
Market Cap Chart
Since July 20, 2017, Cibus's market cap has decreased from $288.70M to $244.92M, a decrease of -15.16%. That is a compound annual growth rate of -2.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 232.10M | -44.63% |
| Dec 29, 2023 | 419.20M | 5,722.22% |
| Dec 30, 2022 | 7.20M | -91.22% |
| Dec 31, 2021 | 82.00M | -47.57% |
| Dec 31, 2020 | 156.40M | -32.29% |
| Dec 31, 2019 | 231.00M | -31.54% |
| Dec 31, 2018 | 337.40M | -44.70% |
| Dec 29, 2017 | 610.10M | 111.33% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atai Life Sciences | 247.76M |
| Senseonics Holdings | 247.39M |
| Sera Prognostics | 247.15M |
| Utah Medical Products | 246.67M |
| Immutep | 245.05M |
| Cybin | 244.30M |
| Tectonic Therapeutic | 243.12M |
| Mersana Therapeutics | 241.05M |